1. Home
  2. SLGL vs HYPR Comparison

SLGL vs HYPR Comparison

Compare SLGL & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • HYPR
  • Stock Information
  • Founded
  • SLGL 1997
  • HYPR 2014
  • Country
  • SLGL Israel
  • HYPR United States
  • Employees
  • SLGL N/A
  • HYPR N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • HYPR Medical Specialities
  • Sector
  • SLGL Health Care
  • HYPR Health Care
  • Exchange
  • SLGL Nasdaq
  • HYPR Nasdaq
  • Market Cap
  • SLGL 69.1M
  • HYPR 55.9M
  • IPO Year
  • SLGL 2018
  • HYPR N/A
  • Fundamental
  • Price
  • SLGL $26.57
  • HYPR $1.39
  • Analyst Decision
  • SLGL
  • HYPR Strong Buy
  • Analyst Count
  • SLGL 0
  • HYPR 3
  • Target Price
  • SLGL N/A
  • HYPR $1.28
  • AVG Volume (30 Days)
  • SLGL 32.9K
  • HYPR 276.6K
  • Earning Date
  • SLGL 11-14-2025
  • HYPR 11-11-2025
  • Dividend Yield
  • SLGL N/A
  • HYPR N/A
  • EPS Growth
  • SLGL N/A
  • HYPR N/A
  • EPS
  • SLGL N/A
  • HYPR N/A
  • Revenue
  • SLGL $23,931,000.00
  • HYPR $10,797,000.00
  • Revenue This Year
  • SLGL N/A
  • HYPR $12.92
  • Revenue Next Year
  • SLGL $31.17
  • HYPR $32.10
  • P/E Ratio
  • SLGL N/A
  • HYPR N/A
  • Revenue Growth
  • SLGL 264.86
  • HYPR N/A
  • 52 Week Low
  • SLGL $4.01
  • HYPR $0.53
  • 52 Week High
  • SLGL $30.00
  • HYPR $1.90
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.38
  • HYPR 62.27
  • Support Level
  • SLGL $23.15
  • HYPR $1.36
  • Resistance Level
  • SLGL $24.85
  • HYPR $1.50
  • Average True Range (ATR)
  • SLGL 2.32
  • HYPR 0.08
  • MACD
  • SLGL -0.41
  • HYPR 0.01
  • Stochastic Oscillator
  • SLGL 61.43
  • HYPR 75.00

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Share on Social Networks: